Strategies for the prevention of postoperative recurrence of Crohn's disease

To review the optimal strategy to prevent recurrence of Crohn's disease (CD) after surgery, with particular emphasis on the risk factors that predict postoperative recurrence, methods of monitoring for recurrence and medications used to prevent postoperative recurrence.

[1]  Takayuki Yamamoto.  Prevention of Postoperative Recurrence in Crohn’s Disease , 2014, Drugs.

[2]  M. Nakahigashi,et al.  Enteral nutrition to suppress postoperative Crohn’s disease recurrence: a five-year prospective cohort study , 2013, International Journal of Colorectal Disease.

[3]  G. Mantzaris,et al.  Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study. , 2012, Journal of Crohn's & colitis.

[4]  H. Ikeuchi,et al.  Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: A 3‐year prospective randomized open trial , 2012, Inflammatory bowel diseases.

[5]  C. Sánchez-Montes,et al.  Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients. , 2012, World journal of gastroenterology.

[6]  E. Savarino,et al.  Adalimumab for the prevention of recurrence after surgery for Crohn’s disease: author’s reply , 2012 .

[7]  M. Kamm,et al.  Postoperative recurrent luminal Crohn's disease: a systematic review. , 2012, Inflammatory bowel diseases.

[8]  L. Peyrin-Biroulet,et al.  Review article: the natural history of postoperative Crohn's disease recurrence , 2012, Alimentary pharmacology & therapeutics.

[9]  T. Hibi,et al.  Interval of less than 5 years between the first and second operation is a risk factor for a third operation for Crohn's disease , 2012, Inflammatory bowel diseases.

[10]  E. Savarino,et al.  Prevention of postoperative recurrence of Crohn's disease by Adalimumab: a case series. , 2011, European journal of gastroenterology & hepatology.

[11]  M. Geraci,et al.  Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn’s Disease: Partial Benefit by Infliximab—A Pilot Study , 2012, Digestive Diseases and Sciences.

[12]  Stuart A. Taylor,et al.  Noninvasive imaging of the small bowel in Crohn's disease: The final frontier , 2011, Inflammatory bowel diseases.

[13]  R. McLeod,et al.  Validating Crohn's disease activity indices for use in assessing postoperative recurrence , 2011, Inflammatory bowel diseases.

[14]  P. Moayyedi,et al.  Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis , 2011, The American Journal of Gastroenterology.

[15]  P. Moayyedi,et al.  5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis , 2011, The American Journal of Gastroenterology.

[16]  M. Regueiro,et al.  Crohn's disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection , 2011, Inflammatory bowel diseases.

[17]  A. Cheifetz,et al.  Meta‐analysis: targeting the intestinal microbiota in prophylaxis for post‐operative Crohn’s disease , 2010, Alimentary pharmacology & therapeutics.

[18]  M. Färkkilä,et al.  Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment , 2010, Scandinavian journal of gastroenterology.

[19]  H. Tilg,et al.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. , 2010, Journal of Crohn's & colitis.

[20]  J. Fletcher,et al.  Endoscopy and MR enteroclysis: Equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection , 2010, Inflammatory bowel diseases.

[21]  P. Tekkis,et al.  Meta-analysis of the Role of Granulomas in the Recurrence of Crohn Disease , 2010, Diseases of the colon and rectum.

[22]  Laurent Beaugerie,et al.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. , 2006, Journal of Crohn's & colitis.

[23]  L. Biancone,et al.  Severity of postoperative recurrence in crohn's disease: Correlation between endoscopic and sonographic findings , 2009, Inflammatory bowel diseases.

[24]  L. Rossini,et al.  Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes , 2009, BMC Research Notes.

[25]  A. Cheifetz,et al.  Interventions for prevention of post-operative recurrence of Crohn's disease. , 2009, The Cochrane database of systematic reviews.

[26]  Takayuki Yamamoto,et al.  Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: A prospective pilot study , 2009, Inflammatory bowel diseases.

[27]  J. Mate,et al.  Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse , 2009, Inflammatory bowel diseases.

[28]  S. Hanauer,et al.  Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis , 2009, The American Journal of Gastroenterology.

[29]  H. Sokol,et al.  S1107 Plexitis As Predictive Factor of Early Postoperative Clinical Recurrence in Crohn's Disease , 2009 .

[30]  H. Sokol,et al.  Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn’s disease , 2009, Gut.

[31]  M. Mohiuddin,et al.  Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease , 2009, The British journal of surgery.

[32]  R. McLeod,et al.  Recurrence of Crohn's Disease After Ileocolic Resection Is Not Affected by Anastomotic Type: Results of a Multicenter, Randomized, Controlled Trial , 2009, Diseases of the colon and rectum.

[33]  M. Regueiro,et al.  Infliximab prevents Crohn's disease recurrence after ileal resection. , 2009, Gastroenterology.

[34]  P. Tekkis,et al.  The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies , 2008, International Journal of Colorectal Disease.

[35]  F. Castiglione,et al.  Oral contrast‐enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease , 2008, Inflammatory bowel diseases.

[36]  L. Biancone,et al.  Non-invasive techniques for assessing postoperative recurrence in Crohn's disease. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[37]  K. Turetschek,et al.  Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy , 2008, European Radiology.

[38]  M. Färkkilä,et al.  Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings , 2008, Inflammatory bowel diseases.

[39]  A. Darzi,et al.  A Meta-Analysis Comparing Incidence of Recurrence and Indication for Reoperation After Surgery for Perforating Versus Nonperforating Crohn's Disease , 2008, The American Journal of Gastroenterology.

[40]  E. Seidman,et al.  Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change , 2007, Alimentary pharmacology & therapeutics.

[41]  S. Purkayastha,et al.  Strictureplasty vs resection in small bowel Crohn's disease: an evaluation of short‐term outcomes and recurrence , 2007, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[42]  L. Biancone,et al.  Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease , 2007, Inflammatory bowel diseases.

[43]  C. Avellini,et al.  Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. , 2007, Archives of internal medicine.

[44]  V. Fazio,et al.  Safety and Efficacy of Strictureplasty for Crohn’s Disease: A Systematic Review and Meta-Analysis , 2007, Diseases of the colon and rectum.

[45]  A. Darzi,et al.  A Meta-Analysis Comparing Conventional End-to-End Anastomosis vs. Other Anastomotic Configurations After Resection in Crohn’s Disease , 2007, Diseases of the colon and rectum.

[46]  M. Plebani,et al.  Fecal Lactoferrin and Calprotectin After Ileocolonic Resection for Crohn’s Disease , 2007, Diseases of the colon and rectum.

[47]  T. Yamamoto,et al.  Impact of long‐term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: a prospective, non‐randomized, parallel, controlled study , 2006, Alimentary pharmacology & therapeutics.

[48]  S. Galandiuk,et al.  Smoking and inflammatory bowel disease: a meta-analysis. , 2006, Mayo Clinic proceedings.

[49]  P. Rutgeerts,et al.  The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence. , 2006, Gastroenterology.

[50]  L. Beaugerie,et al.  Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery , 2005, Gut.

[51]  Giovanni Simonetti,et al.  Virtual Colonoscopy Compared With Conventional Colonoscopy for Stricturing Postoperative Recurrence in Crohn's Disease , 2003, Inflammatory bowel diseases.

[52]  M. Keighley,et al.  Wide-lumen stapled anastomosisvs. conventional end-to-end anastomosis in the treatment of Crohn's disease , 2001, Diseases of the colon and rectum.

[53]  Takayuki Yamamoto,et al.  Smoking and disease recurrence after operation for Crohn's disease , 2000, The British journal of surgery.

[54]  O Bernell,et al.  Risk factors for surgery and postoperative recurrence in Crohn's disease. , 2000, Annals of surgery.

[55]  M. Keighley,et al.  Stapled functional end-to-end anastomosis versus sutured end-to-end anastomosis after ileocolonic resection in Crohn disease. , 1999, Scandinavian journal of gastroenterology.

[56]  M. Hashemi,et al.  Side-to-side stapled anastomosis may delay recurrence in Crohn's disease. , 1998, Diseases of the colon and rectum.

[57]  J. Goldblum,et al.  Effect of resection margins on the recurrence of Crohn's disease in the small bowel. A randomized controlled trial. , 1996, Annals of surgery.

[58]  W. Grigioni,et al.  Factors affecting recurrence in Crohn's disease Results of a prospective audit , 1996, International Journal of Colorectal Disease.

[59]  M. Traina,et al.  Smoking habits and recurrence in Crohn's disease. , 1994, Gastroenterology.

[60]  V. Fazio,et al.  Do microscopic abnormalities at resection margins correlate with increased anastomotic recurrence in Crohn's disease? , 1991, Diseases of the colon and rectum.

[61]  P. Rutgeerts,et al.  Predictability of the postoperative course of Crohn's disease. , 1990, Gastroenterology.

[62]  D. Sachar,et al.  Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. , 1988, Gut.

[63]  F. T. de Dombal,et al.  Factors affecting recurrence after surgery for Crohn's disease. , 1988, Scandinavian journal of gastroenterology. Supplement.

[64]  J. Arnaud,et al.  Does the histologic appearance at the margin of resection affect the postoperative recurrence rate in Crohn's disease? , 1987, The American surgeon.

[65]  J. Fielding.  Risk factors for postoperative recurrence of Crohn's disease. , 1984, Gastroenterology.

[66]  R. Beart,et al.  The importance of disease-free margins in resections for Crohn's disease , 1983, Diseases of the colon and rectum.

[67]  R. Kåresen,et al.  Crohn's disease: long-term results of surgical treatment. , 1981, Scandinavian journal of gastroenterology.

[68]  D. Franchimont,et al.  Crohn's Disease , 1976, The Lancet.

[69]  F Kern,et al.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.

[70]  I. Leodolter.  [Crohn's disease]. , 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.